Bortezomib: An Anti-Tumor Agent
Created 3 months ago by marykudro

Bortezomib is primarily introduced for the treatment of patients with multiple myeloma who haven't been successfully treated with at least a couple of previous therapies. The bortezomib 2 mg price may range from Rs. 2,400 to Rs. 16,500 for a supply of vial of one injection. Bortezomib is administered by a doctor as an injection into your vein (intravenously, or IV) or under your skin (subcutaneously, or SC). It must not be administered into your spinal fluid (intrathecally). Bortezomib has shown effective outcomes and it is well tolerated when considered as part of the first-line regimen in patients who haven't been previously treated for multiple myeloma.

https://www.ikrispharmanetwork.com/bortezomib-bortenat/